Skip to Main Content

Author Details

Siddhartha Deb
Olivia Newton-John Cancer Research Institute
2002
41
20
PMIDPaper TitleJournal TitlePublished Year
36831687Prognostic and Predictive Biomarkers in Familial Breast Cancer.Cancers (Basel)2023
35186255Gynaecomastia-like change of a female breast with tri-layer ductal epithelium as described in the male breast.J Surg Case Rep2022
35565421Paracrine IL-6 Signaling Confers Proliferation between Heterogeneous Inflammatory Breast Cancer Sub-Clones.Cancers (Basel)2022
34420794Not all low grade dysplasia in Barrett's oesophagus is the same: using specific histological criteria in predicting progression to neoplasia.Pathology2021
31100936Immunoprofiling of Breast Cancer Antigens Using Antibodies Derived from Local Lymph Nodes.Cancers (Basel)2019
31482136Tumor inherent interferon regulators as biomarkers of long-term chemotherapeutic response in TNBC.NPJ Precis Oncol2019
31160311Retraction: The E3-ligase E6AP Represses Breast Cancer Metastasis via Regulation of ECT2-Rho Signaling.Cancer Res2019
29658001Glut-1 expression in small cervical biopsies is prognostic in cervical cancers treated with chemoradiation.Clin Transl Radiat Oncol2017
28257959The Immune Microenvironment, Genome-wide Copy Number Aberrations, and Survival in Mesothelioma.J Thorac Oncol2017
28477016E6AP promotes prostate cancer by reducing p27 expression.Oncotarget2017
28211079GATA3 expression in triple-negative breast cancers.Histopathology2017
28369925Cousins not twins: intratumoural and intertumoural heterogeneity in syndromic neuroendocrine tumours.J Pathol2017
28416734The angiotensin receptor blocker, Losartan, inhibits mammary tumor development and progression to invasive carcinoma.Oncotarget2017
26768033The cancer genetics and pathology of male breast cancer.Histopathology2016
27780599Calretinin but not caveolin-1 correlates with tumour histology and survival in malignant mesothelioma.Pathology2016
27231202The E3-ligase E6AP Represses Breast Cancer Metastasis via Regulation of ECT2-Rho Signaling.Cancer Res2016
25633981Functional and molecular characterisation of EO771.LMB tumours, a new C57BL/6-mouse-derived model of spontaneously metastatic mammary cancer.Dis Model Mech2015
26152113Comparative microRNA profiling of sporadic and BRCA1 associated basal-like breast cancers.BMC Cancer2015
26173619¹⁸F-FDG PET/CT following chemoradiation of uterine cervix cancer provides powerful prognostic stratification independent of HPV status: a prospective cohort of 105 women with mature survival data.Eur J Nucl Med Mol Imaging2015
24077944Characterization of a novel tumorigenic esophageal adenocarcinoma cell line: OANC1.Dig Dis Sci2014
25490678Mutational profiling of familial male breast cancers reveals similarities with luminal A female breast cancer with rare TP53 mutations.Br J Cancer2014
25464844Cohesin Rad21 mediates loss of heterozygosity and is upregulated via Wnt promoting transcriptional dysregulation in gastrointestinal tumors.Cell Rep2014
25331261Methylation profiling of ductal carcinoma in situ and its relationship to histopathological features.Breast Cancer Res2014
24916286Lymph node status as a prognostic indicator after preoperative neoadjuvant chemoradiotherapy of rectal cancer.Colorectal Dis2014
24874483COX-2 expression is predictive for early relapse and aromatase inhibitor resistance in patients with ductal carcinoma in situ of the breast, and is a target for treatment.Br J Cancer2014
24548858RAD21 cohesin overexpression is a prognostic and predictive marker exacerbating poor prognosis in KRAS mutant colorectal carcinomas.Br J Cancer2014
24406338FOXP3 over-expression inhibits melanoma tumorigenesis via effects on proliferation and apoptosis.Oncotarget2014
23434054Frequency of fibroblast growth factor receptor 1 gene amplification in oral tongue squamous cell carcinomas and associations with clinical features and patient outcome.Oral Oncol2013
23971979PIK3CA mutations are frequently observed in BRCAX but not BRCA2-associated male breast cancer.Breast Cancer Res2013
23935846The role of Cancer-Testis antigens as predictive and prognostic markers in non-small cell lung cancer.PLoS One2013
21768359Sensitization of BCL-2-expressing breast tumors to chemotherapy by the BH3 mimetic ABT-737.Proc Natl Acad Sci U S A2012
23146383Genotypic and phenotypic analysis of familial male breast cancer shows under representation of the HER2 and basal subtypes in BRCA-associated carcinomas.BMC Cancer2012
22543203A prospective pathologic study to define the clinical target volume for partial breast radiation therapy in women with early breast cancer.Int J Radiat Oncol Biol Phys2012
21115342Cancer-testis antigen expression in primary cutaneous melanoma has independent prognostic value comparable to that of Breslow thickness, ulceration and mitotic rate.Eur J Cancer2011
21930782Gata-3 negatively regulates the tumor-initiating capacity of mammary luminal progenitor cells and targets the putative tumor suppressor caspase-14.Mol Cell Biol2011
21317925The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene.Oncogene2011
20958947Microcystic adnexal carcinoma of the skin: the role of adjuvant radiotherapy.J Med Imaging Radiat Oncol2010
19815416Primary anaplastic pilocytic astrocytoma.J Clin Neurosci2009
18519755ECSA/DPPA2 is an embryo-cancer antigen that is coexpressed with cancer-testis antigens in non-small cell lung cancer.Clin Cancer Res2008
16411876Cryptococcal dementia in a patient with sarcoidosis.Med J Aust2006
12082628TERT regulates cell survival independent of telomerase enzymatic activity.Oncogene2002
  • 1 - 41 of 41

Recommended Authors

University of Bern
Career Start Year 2009
Number of shared co-authors 3
Instituto Do Cancer Do Estado de Sao Paulo
Career Start Year 2009
Number of shared co-authors 4
University of Basel
Career Start Year 2008
Number of shared co-authors 1
Stanford University School of Medicine
Career Start Year 2008
Number of shared co-authors 0
University of British Columbia
Career Start Year 2007
Number of shared co-authors 2
Memorial Sloan Kettering Cancer Center
Career Start Year 2007
Number of shared co-authors 3
Pathology Queensland The Royal Brisbane and Women's Hospital Brisbane Qld Australia.
Career Start Year 2007
Number of shared co-authors 6
University of Turin, Candiolo Cancer Institute, FPO-IRCCS
Career Start Year 2005
Number of shared co-authors 1
Beth Israel Deaconess Medical Center, Harvard Medical School
Career Start Year 2004
Number of shared co-authors 0
Lund University
Career Start Year 2003
Number of shared co-authors 0
UQ Centre for Clinical Research, The University of Queensland
Career Start Year 2003
Number of shared co-authors 3
The Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 3
IEO European Institute of Oncology IRCCS
Career Start Year 2002
Number of shared co-authors 1
Memorial Sloan Kettering Cancer Center
Career Start Year 2002
Number of shared co-authors 3
UCD Conway Institute, University College Dublin
Career Start Year 2001
Number of shared co-authors 0
Lund University and Skane University Hospital
Career Start Year 1997
Number of shared co-authors 0
Memorial Sloan-Kettering Cancer Center
Career Start Year 1996
Number of shared co-authors 10
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1996
Number of shared co-authors 1
University Health Network
Career Start Year 1994
Number of shared co-authors 2
University of British Columbia
Career Start Year 1994
Number of shared co-authors 7
Westmead Institute for Medical Research, The University of Sydney
Career Start Year 1993
Number of shared co-authors 6
University of Edinburgh
Career Start Year 1992
Number of shared co-authors 6
Cancer Research UK Cambridge Institute, University of Cambridge
Career Start Year 1992
Number of shared co-authors 4
Vanderbilt University Medical Center
Career Start Year 1990
Number of shared co-authors 0
Erasmus Medical Center (MC) Cancer Institute
Career Start Year 1989
Number of shared co-authors 2
University Medical Center Utrecht
Career Start Year 1989
Number of shared co-authors 2
University of California San Francisco
Career Start Year 1984
Number of shared co-authors 2
Pathologisches Institut, Universitatsklinikum Heidelberg
Career Start Year 1981
Number of shared co-authors 3
University of Toronto
Career Start Year 1977
Number of shared co-authors 5
Foundation Medicine
Career Start Year 1974
Number of shared co-authors 0

Collaborators

Australia Olivia Newton-John Cancer Research Institute, La Trobe University
Co-authored papers 4
Peter MacCallum Cancer Centre
Co-authored papers 4
Olivia Newton-John Cancer Research Institute
Co-authored papers 3
Olivia Newton-John Cancer Research Institute
Co-authored papers 3
Royal Melbourne Hospital
Co-authored papers 3
Olivia Newton-John Cancer Research Institute
Co-authored papers 3
Churchill Hospital
Co-authored papers 3
Peter MacCallum Cancer Centre
Co-authored papers 3
Yale University School of Medicine
Co-authored papers 2
Peter MacCallum Cancer Centre
Co-authored papers 2
University of Sydney
Co-authored papers 2
New York-Presbyterian Hospital
Co-authored papers 2
St. Vincent's Hospital, University of Melbourne
Co-authored papers 2
University of California los angeles
Co-authored papers 2
Research Institute in Oncology and Hematology
Co-authored papers 2
Austin Hospital
Co-authored papers 2
School of Public Health, Imperial College London
Co-authored papers 2
Northern Hospital
Co-authored papers 2
University of Queensland
Co-authored papers 2
From Population Health Services (Chen)
Co-authored papers 2
St Vincent's Hospital
Co-authored papers 2
The University of Melbourne
Co-authored papers 2
Co-authored papers 1
Co-authored papers 1
Olivia Newton-John Cancer Research Institute
Co-authored papers 1
Co-authored papers 1
Olivia Newton-John Cancer Wellness and Research Centre
Co-authored papers 1
Peter MacCallum Cancer Centre
Co-authored papers 1
Maastricht University
Co-authored papers 1
Co-authored papers 1